Surgical treatment of pancreatic cancer

Annals of the New York Academy of Sciences

Volumn 1138, Issue , 2008, Pages 169-180

  Loos, Martin ^a   Kleeff, Jörg ^a   Friess, Helmut ^a   Büchler, Markus W ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer; Pancreas; Pancreatectomy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GEMCITABINE;

ANASTOMOSIS; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CLASSICAL KAUSCH WHIPPLE PROCEDURE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LYMPHADENECTOMY; METASTASIS; PANCREAS CANCER; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; SURGICAL TECHNIQUE; VASCULAR SURGERY;

EID: 53149112396     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1414.024     Document Type: Conference Paper

References (114)

1. Jemal, A. et al. 2007. Cancer statistics 2007. CA Cancer J. Clin. 57 : 43 66.
2. Ozawa, F. et al. 2001. Treatment of pancreatic cancer: the role of surgery. Dig. Dis. 19 : 47 56.
3. Cameron, J.L. et al. 2006. One thousand consecutive pancreaticoduodenectomies. Ann. Surg. 244 : 10 15.
4. Richter, A. et al. 2003. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. World J. Surg. 27 : 324 329.
5. Carpelan-Holmstrom, M. et al. 2005. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54 : 385 387.
6. Wagner, M. et al. 2004. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br. J. Surg. 91 : 586 594.
7. Yeo, C.J. et al. 1997. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg. 226 : 248 257.
8. Buchler, M.W. et al. 2003. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch. Surg. 138 : 1310 1314.
9. Fernandez-del Castillo, C. et al. 1995. Standards for pancreatic resection in the 1990s. Arch. Surg. 130 : 295 299.
10. Neoptolemos, J.P. et al. 1997. Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br. J. Surg. 84 : 1370 1376.
11. Birkmeyer, J.D. et al. 2002. Hospital volume and surgical mortality in the United States. N. Engl. J. Med. 346 : 1128 1137.
12. Begg, C.B. et al. 1998. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280 : 1747 1751.
13. Sener, S.F. et al. 1999. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the national cancer database. J. Am. Coll. Surg. 189 : 1 7.
14. Kausch, W. et al. 1912. Das Karzinoma der Papilla duodeni und seine radikale Entfernung. Beitr. Klin. Chir. 78 : 439 486.
15. Whipple, A.O. et al. 1935. Treatment of carcinoma of the ampulla of Vater. Ann. Surg. 102 : 763 768.
16. Seiler, C.A. et al. 2000. Randomized prospective trial of pylorus-preserving vs. classical duodenopancreatectomy (Whipple Procedure): Initial clinical results. J. Gastrointest. Surg. 4 : 443 452.
17. Seiler, C.A. et al. 2005. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection - long term results. Br. J. Surg. 92 : 547 556.
18. Lin, P.W. et al. 1999. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br. J. Surg. 86 : 603 607.
19. Lin, P.W. et al. 2005. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 52 : 1601 1604.
20. Tran, K.T. et al. 2004. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann. Surg. 240 : 738 745.
21. Wenger, F.A. et al. 1999. [Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy]. Chirurg 70 : 1454 1459. German.
22. Diener, M.K. et al. 2007. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann. Surg. 245 : 187 200.
23. Pedrazzoli, S. et al. 1999. A surgical and pathological based classification of resective treatment of pancreatic cancer. Dig. Surg. 16 : 337 345.
24. Lillemoe, K.D. et al. 1999. Distal pancreatectomy: indications and outcomes in 235 patients. Ann. Surg. 229 : 693 700.
25. Henne-Bruns, D. et al. 2000. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J. Surg. 24 : 595 601.
26. Gazzaniga, G.M. et al. 2001. D1 versus D2 pancreatoduodenectomy in surgical therapy of pancreatic head cancer. Hepatogastroenterology 48 : 1471 1478.
27. Farnell, M.B. et al. 2005. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 : 618 630.
28. Yeo, C.J. et al. 2002. Pancreaticoduodenectomy with or without extended distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann. Surg. 236 : 355 368.
29. Pedrazzoli, S. et al. 1998. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann. Surg. 228 : 508 517.
30. Nimura, Y. et al. 2004. Regional versus extended lymph node dissection in radical pancreaticoduodenectomy for pancreatic cancer: a multicenter, randomized controlled trial. HPB 6 (Suppl. 1 S2.
31. Neoptolemos, J.P. et al. 2004. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N. Engl. J. Med. 350 : 1200 1210.
32. Picozzi, V.J. et al. 2003. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am. J. Surg. 185 : 476 480.
33. Czito, B.G. et al. 2006. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J. Clin. Oncol. 24 : 656 662.
34. Mornex, F. et al. 2006. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: the French SFRO-FFCD 97-04 Phase II trial. Int. J. Radiat. Oncol. Biol. Phys. 65 : 1471 1478.
35. Krempien, R. et al. 2005. Randomized phase II study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer - PARC: study protocol. BMC Cancer 5 : 131.
36. Kastl, S. et al. 2000. Neoadjuvant radio-chemotherapy in advanced primarily non-resectable carcinomas of the pancreas. Eur. J. Surg. Oncol. 26 : 578 582.
37. Bramhall, S.R. et al. 1995. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br. J. Surg. 82 : 111 115.
38. Watson, K. 1944. Carcinoma of the ampulla of Vater. Successful radical resection. Br. J. Surg. 31 : 368.
39. Traverso, L.W. & W. P. Longmire Jr. 1978. Preservation of the pylorus in the pancreaticoduodenectomy. Surg. Gynecol. Obstet. 146 : 959 962.
40. Friess, H. et al. 1999. The impact of different types of surgery in pancreatic cancer. Eur. J. Surg. Oncol. 25 : 124 131.
41. Grace, P.A. et al. 1990. Pylorus-preserving pancreatoduodenectomy: an overview. Br. J. Surg. 77 : 968 974.
42. Warshaw, A.L. et al. 1985. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. Surg. Gynecol. Obstet. 160 : 1 4.
43. Roder, J.D. et al. 1992. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br. J. Surg. 79 : 152 155.
44. Park, Y.C. et al. 2003. Factors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy. J. Am. Coll. Surg. 196 : 859 865.
45. Poon, T.P. et al. 2001. Opinions and commentary on treating pancreatic cancer. Surg. Clin. North Am. 81 : 625 636.
46. American Gastroenterological Association. 1999. Medical Position Statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 117 : 163 1484.
47. Berberat, P.O. et al. 1999. Prevention and treatment of complications in pancreatic cancer surgery. Dig. Surg. 16 : 327 336.
48. Z'graggen, K. et al. 2002. How to do a safe pancreatic anastomosis. J. Hepatobiliary Pancreat. Surg. 9 : 733 737.
49. van Berge Henegouwen, M.I. et al. 1997. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J. Am. Coll. Surg. 185 : 18 24.
50. Muscari, F. et al. 2006. Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery 139 : 591 598.
51. Bartoli, F.G. et al. 1991. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res. 11 : 1831 1848.
52. Lin, J.W. et al. 2004. Risk factors and outcomes in postpanceaticoduodenectomy pancreaticocutaneous fistula. J. Gastrointest. Surg. 8 : 951 959.
53. Schafer, M. et al. 2002. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann. Surg. 236 : 137 148.
54. Kazanijan, K.K. et al. 2005. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch. Surg. 140 : 849 854.
55. Zenilman, M.E. 2000. Use of pancreaticogastrostomy for pancreatic reconstruction after pancreaticoduodenectomy. J. Clin. Gastroenterol. 31 : 11 18.
56. Bassi, C. et al. 2005. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann. Surg. 242 : 767 771.
57. Duffas, J.P. et al. 2005. A controlled randomized multicenter trial of pancreatogastrostomy or pancreatojejunostomy after pancreatoduodenectomy. Am. J. Surg. 189 : 720 729.
58. Yeo, C.J. et al. 1995. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann. Surg. 222 : 580 588.
59. Wente, M.N. et al. 2007. Pancreaticojejunostomy versus pancreaticogastrostomy: a systematic review and meta-analysis. Am. J. Surg. 193 : 171 183.
60. Tran, K. et al. 2002. Occlusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial. Ann. Surg. 236 : 422 428.
61. D'Andrea, A.A. et al. 1994. Human fibrin sealant in pancreatic surgery: is it useful in preventing fistula? A prospective randomized study. Ital. J. Gastroenterol. 26 : 283 286.
62. Suc, B. et al. 2003. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection. Ann. Surg. 237 : 57 65.
63. Pedrazzoli, S. et al. 2002. Role of surgery in the treatment of bilio-pancreatic cancer: the European experience. Semin. Oncol. 29 (6, Suppl. 20 S23 S30.
64. Sheehan, M.K. et al. 2002. Distal pancreatectomy: does the method of closure influence fistula formation? The Am. Surgeon 68 : 264 268.
65. Aldridge, M.C. et al. 1991. Distal pancreatectomy with and without splenectomy. Br. J. Surg. 78 : 976 979.
66. Kleeff, J. et al. 2007. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann. Surg. 245 : 573 582.
67. Shoup, M. et al. 2002. The value of splenic preservation with distal pancreatectomy. Arch. Surg. 137 : 164 168.
68. Richardson, D.Q. et al. 1989. Distal pancreatectomy with and without splenectomy. Am. Surg. 55 : 21 25.
69. Warshaw, A.L. et al. 1988. Conservation of the spleen with distal pancreatectomy. Arch. Surg. 123 : 550 553.
70. Schwarz, R.E. et al. 1999. The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J. Am. Coll. Surg. 188 : 516 521.
71. Fabre, J.M. et al. 1996. Surgery for left-sided pancreatic cancer. Br. J. Surg. 83 : 1065 1070.
72. Johnson, C.D. et al. 1993. Resection for adenocarcinoma of the body and tail of the pancreas. Br. J. Surg. 80 : 1177 1179.
73. Brennan, M.F. et al. 1996. Management of adenocarcinoma of the body and tail of the pancreas. Ann. Surg. 223 : 506 512.
74. Sohn, T.A. et al. 2000. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators. J. Gastrointest. Surg. 4 : 567.
75. Fortner, J.G. 1973. Regional resection and pancreatic carcinoma. Surgery 73 : 799 800.
76. Fortner, J.G. et al. 1984. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann. Surg. 199 : 418 425.
77. Pedrazzoli, S. et al. 1999. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig. Surg. 16 : 337 345.
78. Ishikawa, O. et al. 1988. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreatic head. Ann. Surg. 208 : 215 220.
79. Manabe, T. et al. 1989. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64 : 1132 1137.
80. Kayahara, M. et al. 1993. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72 : 2118 2123.
81. Nagai, H. 1987. [An anatomical and pathological study of autopsy material on the metastasis of pancreatic cancer to para-aortic lymph nodes]. Nippon Geka Gakkai Zasshi 88 : 308 317.
82. Nagakawa, T. et al. 1989. The spread and prognosis of carcinoma in the region of the pancreatic head. Jpn. J. Surg. 19 : 510 518.
83. Ozaki, H. et al. 1983. Lymph node dissection in radical resection for carcinoma of the head of the pancreas and periampullary region. Jpn. J. Clin. Oncol. 13 : 371 377.
84. Ishikawa, O. et al. 1992. Preoperative indications for extended pancreatectomy for locally advanced pancreatic cancer involving the portal vein. Ann. Surg. 215 : 231 236.
85. Ishikawa, O. et al. 1984. [Clinico-pathological study on the appropriate range of pancreatic head cancer]. Nippon Geka Gakkai Zasshi 85 : 363 369.
86. Kawarada, Y. et al. 1999. Modified standard pancreaticoduodenectomy for the treatment of pancreatic head cancer. Digestion 60 (Suppl. 1 S120 S125.
87. Goldberg, M. et al. 1987. Wide local excision as an alternative treatment for periampullary carcinoma. Am. J. Gastroenterol. 82 : 1169 1171.
88. Miyazaki, I. 1989. [Significance of extensive surgery in pancreatic cancer]. Gan To Kagaku Ryoho 16 (4 Pt 2-1 1064 1069.
89. Miyazai, I. et al. 1992. [Extensive radical surgery for carcinomas of the head of the pancreas]. Gan To Kagaku Ryoho 19 : 2333 2337.
90. Nagakawa, T. et al. 1996. Results of extensive surgery for pancreatic carcinoma. Cancer 77 : 640 645.
91. Sindelar, W.F. 1989. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch. Surg. 124 : 127 132.
92. Imaizumi, T. et al. 1998. Extended radical Whipple resection for cancer of the pancreatic head: operative procedures and results. Dig. Surg. 15 : 299 307.
93. Riall, T.S. et al. 2005. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - part 3: update on 5-year survival. J. Gastrointest. Surg. 9 : 1191 1204.
94. Michalski, C.W. et al. 2007. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. 94 : 265 273.
95. Fuhrman, G.M. et al. 1996. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann. Surg. 223 : 154 162.
96. Harrison, L.E. et al. 1996. Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication to resection? Ann. Surg. 224 : 342 349.
97. Leach, S.D. et al. 1998. Survival following pancreaticoduodenectomy with resection of superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br. J. Surg. 85 : 611 617.
98. Hartel, M. et al. 2002. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur. J. Surg. 168 : 707 712.
99. Evans, D.B. 2005. Preoperative chemoradiation for pancreatic cancer. Semin. Oncol. 32 (6, Suppl. 9 S25 S29.
100. Pipas, J.M. et al. 2005. Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma. Ann. Surg. Oncol. 12 : 995 1004.
101. Kleeff, J. et al. 2007. Neoadjuvant therapy for pancreatic cancer. Br. J. Surg. 94 : 261 262.
102. Bakkevold, K.E. et al. 1993. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomized multicenter study. Eur. J. Cancer 29A : 698 703.
103. Takada, T. et al. 2002. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95 : 1685 1695.
104. Stocken, D.D. et al. 2005. Meta-analysis of randomized adjuvant therapy trials for pancreatic cancer. Br. J. Cancer 92 : 1372 1381.
105. Oettle, H. et al. 2007. Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curative-intent resection of pancreatic cancer. A randomized controlled trial. JAMA 297 : 267 277.
106. Kalser, M.H. et al. 1985. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg. 120 : 899 903.
107. Klinkenbijl, J.H. et al. 1999. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann. Surg. 230 : 776 782.
108. Khanna, A. et al. 2006. Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question. J. Gastrointest. Surg. 10 : 689 697.
109. The Gastrointestinal Tumor Study Group. 1979. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann. Surg. 189 : 205 208.
110. Yeo, C.J. et al. 1997. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann. Surg. 225 : 621 633.
111. Verbeke, C.S. et al. 2006. Redefining the R1 resection in pancreatic cancer. Br. J. Surg. 93 : 1232 1237.
112. Knaebel, H.P. et al. 2005. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI: study protocol. BMC Cancer 5 : 37.
113. Shrikhande, S.V. et al. 2007. Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann. Surg. 14 : 118 127.
114. Kleeff, J. et al. 2007. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann. Surg. 245 : 566 572.